Drugs / FK199B
last change Jul 2007 re-read 2 minutes ago

FK199B

Developed for
sleep disorder, initiating and maintaining sleep
Investigated by
Astellas Pharma Inc

Trials 1 · a red edge is where a trial was stopped

2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT00999219 Mar 2006 → Jul 2007 sleep disorder, initiating and maintaining sleep Astellas Pharma Inc Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as FK199B ClinicalTrials.gov intervention name — accepted as the source's own label NCT00999219